Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nicholas W. Baxter currently holds 52,000 shares of Lexaria Bioscience Corp. (LEXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicholas W. Baxter has been a net seller of LEXX stock. They have purchased $167.3K and sold $311.5K worth of shares.
Nicholas W. Baxter's most recent insider trade was on Jul 26, 2024, when they sold 12,000 shares at $0.00 per share.
Nicholas W. Baxter serves as Executive at Lexaria Bioscience Corp. (LEXX). They have executed 12 insider transactions totaling $478.8K over their tenure at the company.
Nicholas W. Baxter holds the position of Executive at Lexaria Bioscience Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Nicholas W. Baxter has shown a selling trading pattern, with $167.3K in total purchases and $311.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nicholas W. Baxter was on Apr 17, 2012, when they sold $250.0K worth of EUENF shares. This transaction involved 5,000,000 shares at $0.05 per share.
Nicholas W. Baxter currently owns 52,000 shares of Lexaria Bioscience Corp. (LEXX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nicholas W. Baxter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nicholas W. Baxter has 12 Form 4 filings on record as an insider at Lexaria Bioscience Corp..
Set alerts for Nicholas W. Baxter and 40,000+ other insiders.